Recent Articles from Investor's Business Daily
SpaceX will work on the initial stages of the newly planned national missile defense system known as the Golden Dome.
Via Investor's Business Daily · October 31, 2025
Pfizer sued Metsera and Novo Nordisk on Friday to prevent Novo's proposed $6.5 billion takeover of the smaller company.
Via Investor's Business Daily · October 31, 2025
The pivot from bitcoin miner to AI power play has proved lucrative for IREN stock, with shares surging more than 500% so far this year. 
Via Investor's Business Daily · October 31, 2025
Microsoft, Google, Amazon, Meta and Apple vow to continue to ride, the AI megatrend.
Via Investor's Business Daily · October 31, 2025
Amazon stock was rallying following its Q3 report, which included an update on its approach to agentic commerce.
Via Investor's Business Daily · October 31, 2025
Warner Bros. Discovery stock jumped after a report that Netflix is the latest suitor interested in acquiring the studio.
Via Investor's Business Daily · October 31, 2025
Roku stock jumped on Friday after the streaming video platform delivered better-than-expected third-quarter results and guidance.
Via Investor's Business Daily · October 31, 2025
Palantir stock hit another record high ahead of its Q3 earnings report. The U.S. government shutdown could impact Q4 guidance.
Via Investor's Business Daily · October 31, 2025
Western Digital stock was soaring to an all-time high after an earnings report that underscored AI-driven demand for hard drives.
Via Investor's Business Daily · October 31, 2025
Amazon, Apple, Google, Meta and Microsoft headlined earnings.
Via Investor's Business Daily · October 31, 2025
Apple stock hit a record high on Friday after the consumer electronics giant forecast a jolly holiday-sales season.
Via Investor's Business Daily · October 31, 2025
The stock popped Friday — poising itself to top a buy zone — on another sales beat from its linchpin drug.
Via Investor's Business Daily · October 31, 2025
Dexcom's solid third-quarter report was overshadowed Friday by its "surprisingly cautious" outlook, and Dexcom stock tumbled.
Via Investor's Business Daily · October 31, 2025
President Trump continues to stress critical mineral development.
Via Investor's Business Daily · October 31, 2025
AbbVie stock dipped early Friday, though the drug giant easily beat views.
Via Investor's Business Daily · October 31, 2025
Goal-setting unfolds in stages. There's excitement at the outset when you set a lofty target. Then you dive in and momentum builds.
Via Investor's Business Daily · October 31, 2025
On Friday, Roku stock hit a noteworthy performance benchmark, seeing its Relative Strength (RS) Rating jump to 84, up from 79 the day before.
Via Investor's Business Daily · October 31, 2025
Wesco International sees its Relative Strength Rating move into the 80-plus level.
Via Investor's Business Daily · October 31, 2025
Apple beat estimates for its fiscal fourth quarter on record iPhone and services revenue. Apple stock rose on the news.
Via Investor's Business Daily · October 30, 2025
Twilio stock rose after the software maker reported Q3 earnings that topped estimates and hiked its full-year revenue outlook.
Via Investor's Business Daily · October 30, 2025
Cloudflare stock wavered after the company reported Q3 earnings that topped estimates and guidance came in slightly above views.
Via Investor's Business Daily · October 30, 2025
Edwards Lifesciences stock jumped late Thursday after the medtech company boosted its 2025 outlook after beating quarterly calls.
Via Investor's Business Daily · October 30, 2025
Reddit stock was lower despite Q3 results that beat estimates, including a 68% jump in revenue for the September period.
Via Investor's Business Daily · October 30, 2025
Amazon stock jumped late Thursday after the tech behemoth reported third-quarter results ahead of Wall Street views.
Via Investor's Business Daily · October 30, 2025
Excluding the impact of Veklury, Gilead Sciences' product sales would have been closer to analysts' forecast.
Via Investor's Business Daily · October 30, 2025
How Mark Minervini manages risk as market concentration fears grow
Via Investor's Business Daily · October 30, 2025
The event with the most significant impact on Bob Costas' successful broadcast career was not any of the dozen Olympic Games he hosted.
Via Investor's Business Daily · October 30, 2025
Ballooning capital expenditures on data centers for artificial intelligence will benefit a host of AI stocks, analysts say.
Via Investor's Business Daily · October 30, 2025
Boeing stock downgraded over worse-than-expected cash flows for the next two years and continued production delays.
Via Investor's Business Daily · October 30, 2025
Novo Nordisk kicked off a battle with Pfizer on Thursday, making an unsolicited $6.5 billion bid for obesity-focused Metsera.
Via Investor's Business Daily · October 30, 2025
Chevron and Exxon Mobil report third-quarter earnings and revenue before the stock market open Friday.
Via Investor's Business Daily · October 30, 2025
Kid-centric online service Roblox beat expectations for Q3 and guided higher than views for the current period. But Roblox stock fell.
Via Investor's Business Daily · October 30, 2025
The Trump-Xi trade truce will delay China's newest export controls on rare earth minerals for a year, but it's unclear if Beijing will allow defense-related shipments.
Via Investor's Business Daily · October 30, 2025
Core Scientific shareholders on Thursday morning are expected to vote on CoreWeave's proposed merger. CoreWeave stock has gained 140% in 2025.
Via Investor's Business Daily · October 30, 2025
Insmed stock surged early Thursday as Argenx stock rose more moderately. The top-notch biotech companies beat third-quarter calls.
Via Investor's Business Daily · October 30, 2025
Biogen stock fell early Thursday after the biotech company cut its 2025 profit outlook due to an expected tax charge.
Via Investor's Business Daily · October 30, 2025
Two S&P 500 stocks soared on earnings, poised for breakouts in Thursday's stock market.
Via Investor's Business Daily · October 30, 2025
Shares jumped early Thursday after the drugmaker easily topped third-quarter forecasts.
Via Investor's Business Daily · October 30, 2025
The company easily beat third-quarter expectations and issued guidance that widely topped forecasts.
Via Investor's Business Daily · October 30, 2025
The company sells a notable vaccine to prevent human papillomavirus. But sales are struggling.
Via Investor's Business Daily · October 30, 2025
Atmus Filtration Techs stock saw a positive improvement to its Relative Strength (RS) Rating on Thursday, with an upgrade from 78 to 81.
Via Investor's Business Daily · October 30, 2025
The upgraded 86 RS Rating puts Stamford, Conn.-based ITT in the top 14% of stocks for price appreciation over the last year.
Via Investor's Business Daily · October 30, 2025
The best growth stocks like Celestica have a good backstory and continue on that trajectory. Several stocks here hit record highs Wednesday.
Via Investor's Business Daily · October 29, 2025
The used car seller's earnings more than doubled while revenue growth accelerated.
Via Investor's Business Daily · October 29, 2025
EBay stock slide despite strong results. Its outlook for the current quarter may be to blame, with profit expectations coming in below views.
Via Investor's Business Daily · October 29, 2025
Software maker ServiceNow reported Q3 earnings that topped estimates and announced a 5 for 1 split for ServiceNow stock.
Via Investor's Business Daily · October 29, 2025
Meta stock retreated late Wednesday after the Facebook parent reported mixed results for the third quarter.
Via Investor's Business Daily · October 29, 2025
Software giant Microsoft beat estimates for its fiscal first quarter thanks to cloud computing and AI services. But Microsoft stock fell.
Via Investor's Business Daily · October 29, 2025
Google stock climbed after the tech giant reported Q3 earnings and revenue that beat estimates while search advertising and cloud revenue came in above views.
Via Investor's Business Daily · October 29, 2025
Shares could rocket, again, Wednesday after the diagnostics company smashed Wall Street's third-quarter calls.
Via Investor's Business Daily · October 29, 2025
Celestica stock pushed higher after it raised guidance on its earnings call, as the stock tops 260% gains in 2025.
Via Investor's Business Daily · October 29, 2025
Wednesday's rate cut is a lock and markets expect further easing in December.
Via Investor's Business Daily · October 29, 2025
Amazon stock is underperforming because of AI concerns as the tech giant prepares to publish third-quarter earnings results.
Via Investor's Business Daily · October 29, 2025
Nvidia stock scored a flurry of price-target hikes after CEO Jensen Huang outlined the road ahead for the AI leader.
Via Investor's Business Daily · October 29, 2025
Uber plans to deploy its robotaxi service using Lucid vehicles next year in the Bay Area.
Via Investor's Business Daily · October 29, 2025
Air taxi maker Joby announced an AI collaboration with Nvidia to advance autonomous flight capabilities for commercial, defense.
Via Investor's Business Daily · October 29, 2025
Quantum computing stocks fell amid an announcement by Nvidia at the fall version of its GTC conference but rebounded Wednesday.
Via Investor's Business Daily · October 29, 2025
GSK stock rose early Wednesday on strong 2025 guidance on the back of its third-quarter sales and earnings beat.
Via Investor's Business Daily · October 29, 2025
Shares of United Therapeutics slipped slightly Wednesday on light sales of its bread-and-butter drug, Tyvaso.
Via Investor's Business Daily · October 29, 2025
UPS stock soared in Tuesday's stock market after earnings and on Wednesday several analysts raised stock price targets.
Via Investor's Business Daily · October 29, 2025
The Dow telecom giant rose on a Q3 earnings beat and a dividend hike.
Via Investor's Business Daily · October 29, 2025
Garmin matched estimates for earnings in the third quarter though its sales were a tad light. Garmin stock fell after the report.
Via Investor's Business Daily · October 29, 2025
A second positive "domino" fell for BridgeBio on Wednesday after the company reported promising results in a genetic disease.
Via Investor's Business Daily · October 29, 2025
The rating upgrade shows that HSBC stock tops 82% of all stocks for price performance over the last 52 weeks.
Via Investor's Business Daily · October 29, 2025
Super Micro Computer shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81.
Via Investor's Business Daily · October 29, 2025
In a welcome move, XP stock saw its Relative Strength Rating improve to 71 on Wednesday, up from 67 a day earlier.
Via Investor's Business Daily · October 29, 2025
Williams-Sonoma stock had its RS Rating upgraded to 75 Wednesday — a nice improvement, but shy of the 80-plus score you prefer to see.
Via Investor's Business Daily · October 29, 2025
Bloom Energy stock rose in afterhours trading, as the fuel cell manufacturer continues its year of major gains.
Via Investor's Business Daily · October 28, 2025
Trump tariffs ratcheted up in August as the White House taxed finished steel imports.
Via Investor's Business Daily · October 28, 2025
Seagate stock was up 3% after its quarterly results, suggesting that the hard-drive maker can add to its AI-powered 2025 rally.
Via Investor's Business Daily · October 28, 2025
Booking stock gained after a Q3 earnings report that saw earnings and sales ahead of Wall Street forecasts.
Via Investor's Business Daily · October 28, 2025
Shares of Neurocrine Biosciences raced ahead late Tuesday on better-than-expected third-quarter sales and earnings.
Via Investor's Business Daily · October 28, 2025
Nvidia celebrated a resurgence in U.S. manufacturing and announced a bunch of corporate alliances at a conference Tuesday. Nvidia stock rose.
Via Investor's Business Daily · October 28, 2025
Boeing reports earnings on Wednesday. The FAA recently lifted its monthly production cap. The Dow Jones manufacturer still faces a strike.
Via Investor's Business Daily · October 28, 2025
Investors are no longer giving companies a free pass on guidance for tariffs, as they had in earlier earnings seasons.
Via Investor's Business Daily · October 28, 2025